631909-35-8

Basic information

• Product Name: 3-METHYL-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL) BENZENAMINE
• Synonyms: 3-METHYL-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL) BENZENAMINE;3-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline;3-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl);Benzenamine,3-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-;3-Methyl-2-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenylamine
• CAS NO: 631909-35-8
• Molecular Formula: C₁₃H₂₀BNO₂
• Molecular Weight: 233.11
• Mol File: 631909-35-8.mol

Chemical Properties

• Boiling Point: 352.3±35.0 °C(Predicted)
• Appearance: /
• Density: 1.03±0.1 g/cm3(Predicted)
• PKA: 4.02±0.11(Predicted)
• CAS DataBase Reference: 3-METHYL-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL) BENZENAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-METHYL-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL) BENZENAMINE(631909-35-8)
• EPA Substance Registry System: 3-METHYL-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL) BENZENAMINE(631909-35-8)

Safety Data

• Hazardous Substances Data: 631909-35-8(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
3-METHYL-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL) BENZENAMINE is used as a reagent for forming bonds with other molecules in various organic synthesis processes. Its boron-containing group facilitates cross-coupling reactions, making it a versatile component in the creation of complex organic compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 3-METHYL-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL) BENZENAMINE is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with specific therapeutic properties, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
3-METHYL-2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL) BENZENAMINE is also utilized in the agrochemical industry as a building block for the synthesis of agrochemicals. Its reactivity and structural features enable the development of new compounds with potential applications in crop protection and other agricultural areas.

Upstream product

• 54879-20-8 2-bromo-3-methylaniline 
• 73183-34-3 bis(pinacol)diborane 

Relevant articles and documents

AGRICULTURAL CHEMICALS

The present invention relates to benzimidazole and benzotriazole compounds which are of use in the field of agriculture as fungicides.

Discovery of a novel allosteric inhibitor scaffold for polyadenosine-diphosphate-ribose polymerase 14 (PARP14) macrodomain 2

The polyadenosine-diphosphate-ribose polymerase 14 (PARP14) has been implicated in DNA damage response pathways for homologous recombination. PARP14 contains three (ADP ribose binding) macrodomains (MD) whose exact contribution to overall PARP14 function in pathology remains unclear. A medium throughput screen led to the identification of N-(2(-9H-carbazol-1-yl)phenyl)acetamide (GeA-69, 1) as a novel allosteric PARP14 MD2 (second MD of PARP14) inhibitor. We herein report medicinal chemistry around this novel chemotype to afford a sub-micromolar PARP14 MD2 inhibitor. This chemical series provides a novel starting point for further development of PARP14 chemical probes.

Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions

Disclosed is a method for treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade, comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of Formula I or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R1, R2, R3, R4 and R7 are defined in the specification, Z is SO or SO2, and Ar is an aromatic or heteroaromatic group as defined herein.

NOVEL THIOPHENE AMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATING COMPLEMENT-MEDIATED DISEASES AND CONDITIONS

Disclosed is a method for treating the symptoms of an acute or chronic disorder mediated by the classical pathway of the complement cascade, comprising administering to a mammal in need of such treatment a therapeutically effective amount of a compound of Formula (I) or a solvate, hydrate or pharmaceutically acceptable salt thereof; wherein R1, R2, R3, R4 and R7 are defined in the specification, Z is SO or SO2, and Ar is an aromatic or heteroaromatic group as defined herein.